What do studies indicate about birth defects after inadvertent use of ethinylestradiol + norgestimate in early pregnancy?

For Lizinna (ethinylestradiol + norgestimate), most recent studies do not indicate a teratogenic effect after inadvertent use in early pregnancy, particularly cardiac anomalies and limb reduction defects; it is not indicated during pregnancy, and suspected pregnancy should be confirmed before discontinuing treatment.